Team:LCG-UNAM-Mexico/Description
From 2009.igem.org
(Difference between revisions)
(→System delivery: benefits and perspectives) |
(→System delivery: benefits and perspectives) |
||
Line 111: | Line 111: | ||
<br>2) '''Refined phage therapy.''' | <br>2) '''Refined phage therapy.''' | ||
- | In addition to bacterial protection, we propose this system to protect humans. This could be using phage therapy to | + | In addition to bacterial protection, we propose the use of this system to protect humans. This could be done using phage therapy to transduce DNA into pathogenic bacteria. It would be an advantage in cases where extra control is needed, as in degrading toxins before killing the pathogen and so avoiding further immune response. Another benefit would be response specificity in '''hacking pathogen-specific regulators''' while the system is bypassed in non-hazardous strains. |
As a first step in this area, we have adapted the kamikaze system to detect pathogens instead of phages. The target pathogen is EHEC and EPEC (Enterohemorragic and Enteropathogenic Escherichia coli). P4 will introduce a specific binding site for a pathogenicity-specific regulator LER, which in turn will activate the [[Team:LCG-UNAM-Mexico/Description#Translation process sabotage| kamikaze system]] | As a first step in this area, we have adapted the kamikaze system to detect pathogens instead of phages. The target pathogen is EHEC and EPEC (Enterohemorragic and Enteropathogenic Escherichia coli). P4 will introduce a specific binding site for a pathogenicity-specific regulator LER, which in turn will activate the [[Team:LCG-UNAM-Mexico/Description#Translation process sabotage| kamikaze system]] |
Revision as of 22:01, 20 October 2009